Zine News

New England Journal of Medicine Publishes Results from Pivotal Study of WAYLIVRA® (volanesorsen) in Patients with Familial Chylomicronemia Syndrome

Mean triglyceride levels decreased 77% in volanesorsen-treated patients versus an 18% increase in patients in placebo group

Publicaciones relacionadas

Botón volver arriba
Cerrar